WASHINGTON (Reuters) - Bayer AG’s heart-surgery drug Trasylol can increase the risk of kidney damage, U.S. health officials warned on Friday, adding that more precautions may be needed in the future.>>> Discuss This Story
WASHINGTON (Reuters) - Bayer AG’s heart-surgery drug Trasylol can increase the risk of kidney damage, U.S. health officials warned on Friday, adding that more precautions may be needed in the future.>>> Discuss This Story
